NBEA: A Potential Drug Target for Neurodegenerative Disorders

Target Name: NBEA

NCBI ID: G26960

NBEA: A Potential Drug Target for Neurodegenerative Disorders

Neurobeachin, Transcript Variant 2 (NBEA) is a protein that is expressed in the nervous system and has been identified as a potential drug target for various neurological disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. NBEA is a small non-coding RNA molecule that is approximately 200 amino acids in length. It is expressed in various tissues throughout the body, including the brain, and is known for its role in the regulation of neural stem cells and neuronal survival.

The research on NBEA began in the 1990s, when a team of scientists at the University of California, San Diego identified the protein in the brain as a potential drug target for neurodegenerative disorders. Since then, numerous studies have been conducted to investigate the functions of NBEA and its potential as a drug.

One of the key functions of NBEA is its role in the regulation of neural stem cells. Neural stem cells are a type of cell that have the ability to develop into any type of nervous system cell. NBEA has been shown to be involved in the regulation of neural stem cell proliferation and differentiation, which may have implications for the development of neurodegenerative disorders.

In addition to its role in neural stem cell regulation, NBEA is also known for its potential as a drug target for neurodegenerative disorders. Studies have shown that NBEA is overexpressed in the brains of individuals with Alzheimer's disease and other neurodegenerative disorders. Overexpression of NBEA has been shown to contribute to the development of neurodegenerative disorders, including Alzheimer's disease.

Another potential function of NBEA is its role in the regulation of neuronal survival. Neurons are the structural and functional units of the nervous system, and they are delicate and sensitive to environmental stressors. NBEA has been shown to be involved in the regulation of neuronal survival, which may have implications for the development of neurodegenerative disorders.

In conclusion, NBEA is a protein that is expressed in the nervous system and has been identified as a potential drug target for various neurological disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. NBEA's functions in the regulation of neural stem cells, neuronal survival, and the regulation of neurodegenerative disorders make it an attractive target for drug development. Further research is needed to fully understand the role of NBEA as a drug target and its potential as a treatment for neurodegenerative disorders.

Protein Name: Neurobeachin

Functions: Binds to type II regulatory subunits of protein kinase A and anchors/targets them to the membrane. May anchor the kinase to cytoskeletal and/or organelle-associated proteins (By similarity)

More Common Targets